Have a feature idea you'd love to see implemented?
Let us know!
VSTM Verastem Inc
Price (delayed)
$3
Market cap
$120.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.35
Enterprise value
$78.98M
Verastem Oncology is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. The company's pipeline is focused on
Highlights
Verastem's EPS has increased by 24% QoQ and by 24% YoY
VSTM's net income is down by 19% year-on-year but it is up by 15% since the previous quarter
Verastem's equity has shrunk by 81% YoY and by 25% QoQ
Verastem's quick ratio has plunged by 65% YoY and by 25% from the previous quarter
Key stats
What are the main financial stats of VSTM
Market
Valuations
Earnings
Shares outstanding
40.24M
Market cap
$120.73M
Enterprise value
$78.98M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.03
Price to sales (P/S)
8.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.9
Revenue
$10M
EBIT
-$84.97M
EBITDA
-$85.14M
Free cash flow
-$102.18M
Per share
Balance sheet
Liquidity
EPS
-$3.35
Free cash flow per share
-$3.8
Book value per share
$0.74
Revenue per share
$0.37
TBVPS
$3.94
Total assets
$105.75M
Total liabilities
$65.74M
Debt
$41.86M
Equity
$18.85M
Working capital
$69.3M
Debt to equity
2.22
Current ratio
3.28
Quick ratio
3.11
Net debt/EBITDA
0.49
Margins
Efficiency
Dividend
EBITDA margin
-851.4%
Gross margin
100%
Net margin
-894.9%
Operating margin
-988.4%
Return on assets
-64.5%
Return on equity
-194.1%
Return on invested capital
-122.7%
Return on capital employed
-112.7%
Return on sales
-849.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VSTM stock price
How has the Verastem stock price performed over time
Intraday
2.74%
1 week
3.09%
1 month
19.52%
1 year
-60.53%
YTD
-63.14%
QTD
0.33%
Financial performance
How have Verastem's revenue and profit performed over time
Revenue
$10M
Gross profit
$10M
Operating income
-$98.84M
Net income
-$89.49M
Gross margin
100%
Net margin
-894.9%
The company's operating income fell by 33% YoY but it rose by 2% QoQ
VSTM's net income is down by 19% year-on-year but it is up by 15% since the previous quarter
Growth
What is Verastem's growth rate over time
Valuation
What is Verastem stock price valuation
P/E
N/A
P/B
4.03
P/S
8.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.9
Verastem's EPS has increased by 24% QoQ and by 24% YoY
Verastem's equity has shrunk by 81% YoY and by 25% QoQ
The stock's P/B is 27% below its last 4 quarters average of 5.5 and 8% below its 5-year quarterly average of 4.4
Efficiency
How efficient is Verastem business performance
Verastem's return on equity has shrunk by 59% YoY and by 23% QoQ
The ROIC has grown by 41% YoY and by 17% from the previous quarter
The ROA has contracted by 12% YoY
Dividends
What is VSTM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VSTM.
Financial health
How did Verastem financials performed over time
The total assets is 61% greater than the total liabilities
Verastem's quick ratio has plunged by 65% YoY and by 25% from the previous quarter
The company's current ratio has shrunk by 64% YoY and by 25% QoQ
Verastem's debt is 122% more than its equity
Verastem's equity has shrunk by 81% YoY and by 25% QoQ
VSTM's debt to equity is up by 31% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.